Europe's PRAC progresses fusafungine review

4 December 2015 - Deborah Wilkes

Archived

The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) has provided an update on its review of the safety and benefit-risk balance of nasal and mouth sprays containing the antibiotic fusafungine.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: